K-numberK252780
Device nameLCD Monitor (CL1902A, CL2103F)
ApplicantShenzhen Beacon Display Technology Co., Ltd.
Product codePGY
Device classClass II
Decision dateDec 19, 2025
DecisionSubstantially Equivalent
Regulation892.2050
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The CL1902A and CL2103F are LCD monitors designed to display radiological images for review, analysis, and diagnosis by trained medical practitioners. The CL1902A is a 19-inch 1.3MP monitor with 1280x1024 resolution, while the CL2103F is a 21.3-inch 2MP monitor with 1600x1200 resolution. Both feature LED backlighting, brightness stabilization, anti-glare screens, and DICOM Part 3.14 calibration. Neither device is intended for mammography.

Technological characteristics

CL1902A uses an IPS panel versus the predicate's VA panel, includes BNC inputs not in the predicate, features different power specifications (<50W vs <28W), and lacks the predicate's ambient light sensor. CL2103F has similar IPS panel technology to its predicate but differs in aspect ratio orientation (4:3 vs 3:4), input/output interfaces, power consumption (<50W vs <54W), and luminance calibration approach. Both devices show minor variations in scanning frequencies and video bandwidth but maintain equivalent pixel pitch to their respective predicates.

Test standards cited

DICOM Part 3.14 for display calibration, AAPM Task Group 18 (TG18) guideline for display performance assessment, and FDA Guidance for Display Devices for Diagnostic Radiology. Testing included spatial resolution measurement, pixel defect analysis, temporal response, luminance verification, DICOM GSDF conformance, and color tracking assessment.

Substantial equivalence argument

The devices are substantially equivalent because they have identical intended uses (displaying radiological images for diagnosis by trained practitioners), demonstrated equivalent display characteristics through bench testing, and their technological differences do not impact safety or effectiveness or introduce new risks. The comparison tables show that despite design variations in panel technology, interfaces, and power specifications, both devices maintain the same fundamental performance metrics and meet the same calibration standards as their predicates.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →